Waystar
Waystar is a healthcare payments technology company whose cloud platform automates revenue cycle management for providers, spanning financial clearance, claim and denial management, and patient payments. It serves roughly 30,000 clients and listed on Nasdaq under "WAY" in June 2024, raising about $968M.
Why interesting to a deal team
Waystar is the reference asset for healthcare RCM: a sponsor-backed platform taken public in 2024. Schauenberg advised that IPO and DeMichiei chairs its audit committee, giving a deal team insider-grade views on RCM benchmarks, exit timing, and diligence on adjacent payments targets.
Experts connected to this company
- Joe SchauenbergAdvised Waystar on its 2024 IPO
- Rob DeMichieiBoard director; chairs Audit, Compliance and ESG Committee
Joe Schauenberg
Managing Director and Head of Healthcare IT Investment Banking
William Blair
He runs William Blair's 25-person healthcare IT banking franchise and has sold or listed marquee RCM assets — Waystar, Knowtion, RevSpring — giving him unmatched sell-side visibility into the space.
Rob DeMichiei
Board Director and Strategic Advisor (Waystar board director; Health Catalyst strategic advisor; former EVP & CFO of UPMC)
Waystar / Health Catalyst (advisory)
Rare buyer-turned-vendor perspective on healthcare RCM: 16 years buying revenue-cycle capability as UPMC's CFO, now governing Waystar's board and advising Health Catalyst on cost analytics.
Sources
- Structured dataPrimarywaystar.com/contact-us
- Page titlePresshealthcaredive.com/news/waystar-healthcare-payment-ipo-digital-health/717403
- Structured dataPrimarywaystar.com